|
1
|
Lau WY and Lai EC: Hepatocellular
carcinoma: Current management and recent advances. Hepatobiliary
Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
|
|
2
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai EC and Lau WY: The continuing
challenge of hepatic cancer in Asia. Surgeon. 3:210–215. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lau WY: Primary liver tumors. Semin Surg
Oncol. 19:135–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lau WY: Management of hepatocellular
carcinoma. J R Coll Surg Edinb. 47:389–399. 2002.PubMed/NCBI
|
|
6
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Llovet JM, Schwartz M and Mazzaferro V:
Resection and liver transplantation for hepatocellular carcinoma.
Semin Liver Dis. 25:181–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Russo FP and Parola M: Stem and progenitor
cells in liver regeneration and repair. Cytotherapy. 13:135–144.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karahuseyinoglu S, Kocaefe C, Balci D,
Erdemli E and Can A: Functional structure of adipocytes
differentiated from human umbilical cord stroma-derived stem cells.
Stem Cells. 26:682–691. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campard D, Lysy PA, Najimi M and Sokal EM:
Native umbilical cord matrix stem cells express hepatic markers and
differentiate into hepatocyte-like cells. Gastroenterology.
134:833–848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu YS, Shih YT, Cheng YC and Min MY:
Transformation of human umbilical mesenchymal cells into neurons in
vitro. J Biomed Sci. 11:652–660. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Feng Xy, Cui BL, Law F, Jiang XW,
Yang LY, Xie QD and Huang TH: Human umbilical cord Wharton's
Jelly-derived mesenchymal stem cells differentiation into
nerve-like cells. Chin Med J (Engl). 118:1987–1993. 2005.
|
|
13
|
Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren
N, Jia HL, Shi J, Wu JC, Dai C, et al: Human mesenchymal stem cells
inhibit metastasis of a hepatocellular carcinoma model using the
MHCC97-H cell line. Cancer Sci. 101:2546–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khakoo AY, Pati S, Anderson SA, Reid W,
Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi's sarcoma. J Exp Med. 203:1235–1247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma Y, Hao X, Zhang S and Zhang J: The in
vitro and in vivo effects of human umbilical cord mesenchymal stem
cells on the growth of breast cancer cells. Breast Cancer Res
Treat. 133:473–485. 2012. View Article : Google Scholar
|
|
16
|
Yang WZ, Zhang Y, Wu F, Min WP, Minev B,
Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH and Hu X: Safety
evaluation of allogeneic umbilical cord blood mononuclear cell
therapy for degenerative conditions. J Transl Med. 8:752010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Li H, Zhang Y, Santella RM and
Weinstein IB: HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB
activity in human hepatoma cells. Int J Cancer. 124:1526–1534.
2009. View Article : Google Scholar :
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-timequantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Kulterer B, Friedl G, Jandrositz A,
Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R,
Preisegger KH and Trajanoski Z: Gene expression profiling of human
mesenchymal stem cells derived from bone marrow during expansion
and osteoblast differentiation. BMC Genomics. 8:702007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Troyer DL and Weiss ML: Wharton's
jelly-derived cells are a primitive stromal cell population. Stem
Cells. 26:591–599. 2008. View Article : Google Scholar
|
|
21
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mareschi K, Ferrero I, Rustichelli D,
Aschero S, Gammaitoni L, Aglietta M, Madon E and Fagioli F:
Expansion of mesenchymal stem cells isolated from pediatric and
adult donor bone marrow. J Cell Biochem. 97:744–754. 2006.
View Article : Google Scholar
|
|
23
|
Sasportas LS, Kasmieh R, Wakimoto H,
Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL, Martuza
RL, Weissleder R and Shah K: Assessment of therapeutic efficacy and
fate of engineered human mesenchymal stem cells for cancer therapy.
Proc Natl Acad Sci USA. 106:4822–4827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Studeny M, Marini FC, Dembinski JL,
Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE and Andreeff
M: Mesenchymal stem cells: Potential precursors for tumor stroma
and targeted-delivery vehicles for anticancer agents. J Natl Cancer
Inst. 96:1593–1603. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsuzuka T, Rachakatla RS, Doi C, Maurya
DK, Ohta N, Kawabata A, Pyle MM, Pickel L, Reischman J, Marini F,
et al: Human umbilical cord matrix-derived stem cells expressing
interferon-beta gene significantly attenuate bronchioloalveolar
carcinoma xenografts in SCID mice. Lung Cancer. 70:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohlsson LB, Varas L, Kjellman C, Edvardsen
K and Lindvall M: Mesenchymal progenitor cell-mediated inhibition
of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol
Pathol. 75:248–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Y, Sun Z, Han Q, Liao L, Wang J, Bian
C, Li J, Yan X, Liu Y, Shao C and Zhao RC: Human mesenchymal stem
cells inhibit cancer cell proliferation by secreting DKK-1.
Leukemia. 23:925–933. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao Y, Yao A, Zhang W, Lu S, Yu Y, Deng L,
Yin A, Xia Y, Sun B and Wang X: Human mesenchymal stem cells
overex-pressing pigment epithelium-derived factor inhibit
hepatocellular carcinoma in nude mice. Oncogene. 29:2784–2794.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baksh D, Yao R and Tuan RS: Comparison of
proliferative and multilineage differentiation potential of human
mesenchymal stem cells derived from umbilical cord and bone marrow.
Stem Cells. 25:1384–1392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang
SH, Yang IH, Han H and Kim H: Differential gene expression
profiling of human umbilical cord blood-derived mesenchymal stem
cells by DNA microarray. Stem Cells. 23:584–593. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rachakatla RS, Marini F, Weiss ML, Tamura
M and Troyer D: Development of human umbilical cord matrix stem
cell-based gene therapy for experimental lung tumors. Cancer Gene
Ther. 14:828–835. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weiss ML, Medicetty S, Bledsoe AR,
Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G and
Troyer D: Human umbilical cord matrix stem cells: Preliminary
characterization and effect of transplantation in a rodent model of
Parkinson's disease. Stem Cells. 24:781–792. 2006. View Article : Google Scholar
|
|
33
|
Ayuzawa R, Doi C, Rachakatla RS, Pyle MM,
Maurya DK, Troyer D and Tamura M: Naive human umbilical cord matrix
derived stem cells significantly attenuate growth of human breast
cancer cells in vitro and in vivo. Cancer Lett. 280:31–37. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ganta C, Chiyo D, Ayuzawa R, Rachakatla R,
Pyle M, Andrews G, Weiss M, Tamura M and Troyer D: Rat umbilical
cord stem cells completely abolish rat mammary carcinomas with no
evidence of metastasis or recurrence 100 days post-tumor cell
inoculation. Cancer Res. 69:1815–1820. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsuzuka T, Rachakatla RS, Doi C, Maurya
DK, Ohta N, Kawabata A, Pyle MM, Pickel L, Reischman J and Marini
F: Human umbilical cord matrix-derived stem cells expressing
interferon-beta gene significantly attenuate bronchioloalveolar
carcinoma xenografts in SCID mice. Lung Cancer. 70:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu CH and Hwang SM: Cytokine interactions
in mesenchymal stem cells from cord blood. Cytokine. 32:270–279.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li M, Li H, Li C, Zhou S, Guo L, Liu H,
Jiang W, Liu X, Li P, McNutt MA and Li G: Alpha fetoprotein is a
novel protein-binding partner for caspase-3 and blocks the
apoptotic signaling pathway in human hepatoma cells. Int J Cancer.
124:2845–2854. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ali MA, Koura BA, El-Mashad N and Zaghloul
MH: The Bcl-2 and TGF-beta1 levels in patients with chronic
hepatitis C, liver cirrhosis and hepatocellular carcinoma. Egypt J
Immunol. 11:83–90. 2004.
|
|
39
|
Li M, Li H, Li C, Guo L, Liu H, Zhou S,
Liu X, Chen Z, Shi S, Wei J, et al: Cytoplasmic alpha-fetoprotein
functions as a co-repressor in RA-RAR signaling to promote the
growth of human hepatoma Bel 7402 cells. Cancer Lett. 285:190–199.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ke CC, Liu RS, Suetsugu A, Kimura H, Ho
JH, Lee OK and Hoffman RM: In vivo fluorescence imaging reveals the
promotion of mammary tumorigenesis by mesenchymal stromal cells.
PLoS One. 8:e696582013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ljujic B, Milovanovic M, Volarevic V,
Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML and
Stojkovic M: Human mesenchymal stem cells creating an
immunosuppressive environment and promote breast cancer in mice.
Sci Rep. 3:22982013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiao W, Mohseny AB, Hogendoorn PC and
Cleton-Jansen AM: Mesenchymal stem cell transformation and sarcoma
genesis. Clin Sarcoma Res. 3:102013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang P, Dong L, Yan K, Long H, Yang TT,
Dong MQ, Zhou Y, Fan QY and Ma BA: CXCR4-mediated osteosarcoma
growth and pulmonary metastasis is promoted by mesenchymal stem
cells through VEGF. Oncol Rep. 30:1753–1761. 2013.PubMed/NCBI
|
